Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Single-use Bioprocessing Probes & Sensors Market Size & Growth Forecast 2026–2035, By Segments (Workflow, End Use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Base Year Value (2025)
USD 3.58 Billion
CAGR (2026-2035)
11.2%
Forecast Year Value (2035)
USD 10.35 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Single-use Bioprocessing Probes & Sensors Market Intelligence Snapshot:
-
Regional Market Dynamics:
- North America captured a 45.38% market share in 2025, driven by its mature biopharmaceutical manufacturing base and widespread use of single-use monitoring technologies in production workflows.
- Asia Pacific is projected to grow at a 12.54% CAGR as expanding biomanufacturing capacity and greater adoption of single-use production systems increase demand for compatible monitoring solutions.
-
Segment Momentum:
- Upstream accounted for a 70.52% market share in 2025 because continuous monitoring of cell culture conditions and process stability is essential for consistent biologics production using single-use technologies.
- CROs & CMOs are the fastest-growing end-use segment as outsourcing expands and flexible multi-client manufacturing increases demand for adaptable single-use monitoring systems that support rapid production changeovers.
-
Market Expansion Drivers:
- Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiency.
- Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring.
- Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors.
-
Leading Market Participants:
Prominent players in the single-use bioprocessing probes & sensors market include Thermo Fisher Scientific Inc. (United States), Sartorius AG (Germany), Danaher Corporation (United States), Merck KGaA (Germany), Mettler-Toledo International Inc. (United States), Hamilton Company (United States), Parker Hannifin Corporation (United States), PreSens Precision Sensing GmbH (Germany), Saint-Gobain S.A. (France), Dover Corporation (United States).
Global Market Forecast Snapshot:
-
Market Outlook:
- 2025 Market Size: USD 3.58 Billion
- 2026 Market Size: USD 15.2 billion
- Projected Market Size: USD 10.35 Billion by 2035
- Growth Forecasts: 11.2% CAGR (2026-2035)
-
Regional and Segment Outlook:
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Upstream (Workflow) | Biopharmaceutical Companies (End Use) | pH Sensor (Type)
- Emerging Opportunity Segment: Upstream (Workflow) | CROs & CMOs (End Use) | pH Sensor (Type)
Market Growth Drivers and Industry Trends
Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiencyAs biopharmaceutical producers shift from stainless-steel systems to disposable process architectures, sensor and probe selection increasingly follows the same logic: minimizing cleaning validation, changeover downtime, and cross-batch contamination exposure. In the single-use bioprocessing probes & sensors market, this adoption pattern is driving demand for pre-calibrated, integration-ready measurement tools that can be installed directly into disposable bags, bioreactors, and flow paths without disrupting aseptic workflows. Buyers are not only replacing conventional instrumentation; they are redesigning process setups around faster turnaround and lower operational complexity, which strengthens market development for single-use pH, dissolved oxygen, pressure, conductivity, and temperature sensing solutions.
Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring
Biomanufacturers increasingly need production platforms that can shift between process scales, product types, and batch volumes without lengthy reconfiguration, making real-time sensing a core requirement rather than a supporting feature. This is influencing market adoption in the single-use bioprocessing probes & sensors market because flexible systems depend on modular, disposable monitoring components that can move with the process from development through commercial manufacturing. Procurement decisions are shaped by how easily sensors integrate with automated control platforms, preserve data continuity during scale-up, and support rapid deployment in multi-product facilities, reinforcing market demand for adaptable probe formats and interoperable sensor technologies.
Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors
The growth of biologics, including more process-sensitive cell and gene therapy workflows, is increasing the need for tighter control over culture conditions, nutrient behavior, metabolite buildup, and other critical process parameters. In the single-use bioprocessing probes & sensors market, this pipeline expansion is contributing to market size growth by pushing manufacturers toward higher-performance disposable sensing solutions that can support complex media environments and shorter, more variable production runs. Process development teams and CDMOs are placing greater emphasis on sensor accuracy, responsiveness, and compatibility with closed single-use systems, since small deviations in these therapies can affect yield, consistency, and batch viability.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiency | 2.00% | High | North America, Europe | High | Near Term |
| Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring | 1.60% | High | Europe, Asia Pacific | High | Near Term |
| Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors | 1.40% | High | North America, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
Regional Demand Dynamics
Largest Region
North America
45.38% Market Share in 2025
North America held a 45.38% share of the single-use bioprocessing probes & sensors market in 2025, bolstered by its well-established biopharmaceutical manufacturing base and broad adoption of single-use systems across process development and commercial production. The region’s leadership is aided by the routine use of advanced monitoring technologies in upstream and downstream workflows, where probes and sensors are integrated to improve batch consistency, reduce contamination risk, and shorten changeover times. Strong concentration of biologics production activity and mature implementation of disposable bioprocessing platforms continue to sustain demand in day-to-day manufacturing operations.
Asia Pacific is projected to expand at a 12.54% CAGR over the forecast period, with growth in the single-use bioprocessing probes & sensors market being impelled by the rapid build-out of biomanufacturing capacity and wider adoption of flexible production infrastructure. As facilities increase their use of single-use bioreactors and modular processing lines, demand rises for compatible sensing solutions that support real-time monitoring without adding cleaning and validation burdens. The region’s momentum is also tied to the practical needs of scaling biologics production efficiently, especially in newer facilities designed around disposable processing formats.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Emerging | Nascent |
| Cost-Sensitive Region | Low | Medium | Low | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Restrictive |
| Demand Drivers | Strong | Moderate | Strong | Moderate | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Low | Low |
| New Entrants / Startups | Moderate | Sparse | Moderate | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Strong | Stable | Weak |
Key Country Insights
United States single-use bioprocessing probes and sensors market is driven by large-scale biopharmaceutical manufacturing and continuous process optimization needs. In the U.S., adoption is concentrated in GMP-compliant facilities where disposable sensors support real-time monitoring, reduce contamination risk, and improve efficiency in biologics production workflows.
Japan’s single-use bioprocessing probes and sensors market is driven by expanding biologics production and strict regulatory expectations in pharmaceutical manufacturing. In Japan, companies adopt disposable sensing technologies to improve contamination control, streamline validation processes, and enhance operational efficiency in high-value drug production.
South Korea’s single-use bioprocessing probes and sensors market is supported by rapid expansion of domestic biopharmaceutical manufacturing capacity. In South Korea, firms integrate single-use sensing systems to accelerate production scalability, support contract manufacturing growth, and maintain quality control in advanced biologics facilities.
Germany’s single-use bioprocessing probes and sensors market is shaped by highly regulated pharmaceutical manufacturing and strong emphasis on process precision. In Germany, manufacturers prioritize validated single-use systems for inline monitoring, ensuring compliance, reproducibility, and high-quality biologics production across industrial biotech facilities.
France’s single-use bioprocessing probes and sensors market is influenced by strong regulatory oversight and growing biomanufacturing investments. In France, adoption is centered on compliant, single-use monitoring systems that enhance process reliability and support vaccine and biologics production environments.
Italy’s single-use bioprocessing probes and sensors market is driven by increasing flexibility needs in biotech production and contract manufacturing operations. In Italy, companies favor disposable sensing solutions that reduce cleaning validation burdens and support agile production across emerging biopharmaceutical facilities.
Segment Leadership and Growth Trends
Within the single-use bioprocessing probes & sensors market, Upstream accounted for a 70.52% share in 2025, reflecting its clear leadership as well as its continued growth momentum. This position is sustained by the operational intensity of upstream bioprocessing, where real-time monitoring of parameters such as cell culture conditions, nutrient balance, and process stability is essential for batch performance and consistency. The same operating environment is also driving faster expansion for Upstream in the single-use bioprocessing probes & sensors market, as manufacturers continue to favor disposable monitoring solutions that fit flexible production setups, reduce turnaround constraints, and support tighter control in biologics development and manufacturing.
End Use Segment Analysis: Biopharmaceutical Companies (Largest Segment) vs CROs & CMOs (Fastest-Growing Segment)
Biopharmaceutical Companies held the largest share of the single-use bioprocessing probes & sensors market in 2025, with a 44.16% share. Their leadership is rooted in the scale and continuity of in-house biologics development and manufacturing activities, where single-use probes and sensors are integrated into routine upstream and downstream workflows to maintain process control, support quality requirements, and improve production efficiency. Because these companies manage substantial volumes of development and commercial manufacturing work, they remain the primary end users sustaining demand in the single-use bioprocessing probes & sensors market.
CROs & CMOs are emerging as the fastest-growing end-use segment in the single-use bioprocessing probes & sensors market as outsourcing activity expands and external service providers handle a rising share of process development and manufacturing programs. Their growth is being supported by the need to run flexible, multi-client facilities where rapid changeovers, lower contamination risk, and efficient scaling are practical advantages of single-use monitoring systems. Compared with fully integrated manufacturers, CROs & CMOs are gaining momentum faster because their operating model depends more directly on adaptable production infrastructure that can accommodate varied client pipelines without lengthy equipment reconfiguration.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Workflow | Upstream, Downstream | Upstream | Upstream |
| End Use | Biopharmaceutical Companies, CROs & CMOs, Others | Biopharmaceutical Companies | CROs & CMOs |
| Type | pH Sensor, Oxygen Sensors, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meter & Sensors, Others | pH Sensor | pH Sensor |
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
1. Thermo Fisher Scientific Inc. (United States)
2. Sartorius AG (Germany)
3. Danaher Corporation (United States)
4. Merck KGaA (Germany)
5. Mettler-Toledo International Inc. (United States)
6. Hamilton Company (United States)
7. Parker Hannifin Corporation (United States)
8. PreSens Precision Sensing GmbH (Germany)
9. Saint-Gobain S.A. (France)
10. Dover Corporation (United States)
In the single-use bioprocessing probes & sensors market, development efforts are increasingly centered on improving measurement accuracy and integration within disposable processing environments. Continuous refinement of sensing technologies is enabling more reliable process monitoring across biomanufacturing workflows. New solution introductions are emerging with greater adaptability for varied production scales. The single-use bioprocessing probes & sensors market reflects a steady shift toward more flexible and contamination-reducing process intelligence systems.
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Thermo Fisher Scientific Inc. | Feb-24 | Thermo Fisher Scientific expanded its biologics manufacturing facility in St. Louis, Missouri, effectively doubling capacity from 2,000L to 5,000L. The expansion supports production of complex biologics targeting cancer, autoimmune diseases, and rare disorders, reinforcing upstream biomanufacturing capabilities linked to single-use bioprocessing demand. |
| Thermo Fisher Scientific Inc. | Feb-22 | Thermo Fisher Scientific invested USD 40 million to expand its single-use technology manufacturing site in Millersburg, Pennsylvania as part of a broader multi-year capacity program. The investment strengthens production capabilities for flexible bioprocessing components used in biologics and vaccine development, including COVID-19-related manufacturing support. |
| Sartorius | Jun-25 | Sartorius completed a multi-year capacity expansion at its Aubagne headquarters in France, increasing output of fluid-management and bioprocessing technologies. The expansion enhances manufacturing scale for single-use system components, supporting growing demand for flexible and scalable bioprocessing infrastructure. |
| Aber Instruments | Nov-25 | Aber Instruments integrated its BioPAT Viamass biomass sensor into Sartorius Ambr 250 single-use vessels, expanding process analytical technology coverage across Sartorius’ bioreactor portfolio. The integration strengthens real-time monitoring capabilities in single-use bioprocessing workflows, improving process control and biomanufacturing efficiency. |
Frequently Asked Questions
What is the current revenue of the single-use bioprocessing probes & sensors market?
The market revenue for single-use bioprocessing probes & sensors is anticipated at USD 3.94 billion in 2026.
How is the single-use bioprocessing probes & sensors industry size expected to evolve during the forecast period?
Single-use Bioprocessing Probes & Sensors Market size is forecasted to reach USD 10.35 billion by 2035 rising from USD 3.58 billion in 2025 at a CAGR of more than 11.2% between 2026 and 2035.
How is single-use technology adoption transforming demand in bioprocessing probes and sensors?
Shift toward disposable bioprocessing systems is increasing demand for pre-calibrated, integration-ready single-use sensors that reduce cleaning validation, contamination risk, and downtime while supporting faster biomanufacturing workflows.
How is the expansion of biologics and cell therapy pipelines influencing sensor requirements in bioprocessing?
Growth in biologics and cell therapy pipelines is increasing demand for high-precision single-use sensors capable of monitoring sensitive culture conditions, supporting consistency, yield optimization, and reliable performance in complex production environments.
Why does the Upstream workflow lead the single-use bioprocessing probes & sensors market?
Upstream accounted for a 70.52% market share in 2025 because continuous monitoring of cell culture conditions and process stability is essential for consistent biologics production using single-use technologies.
Which end-use segment is growing the fastest in the single-use bioprocessing probes & sensors market?
CROs & CMOs are the fastest-growing end-use segment as outsourcing expands and flexible multi-client manufacturing increases demand for adaptable single-use monitoring systems that support rapid production changeovers.
Why is North America the largest market for single-use bioprocessing probes and sensors?
North America captured a 45.38% market share in 2025, driven by its mature biopharmaceutical manufacturing base and widespread use of single-use monitoring technologies in production workflows.
What factors are accelerating growth in the Asia Pacific single-use bioprocessing probes and sensors market?
Asia Pacific is projected to grow at a 12.54% CAGR as expanding biomanufacturing capacity and greater adoption of single-use production systems increase demand for compatible monitoring solutions.
Which companies are driving growth in the single-use bioprocessing probes & sensors landscape?
Prominent players in the single-use bioprocessing probes & sensors market include Thermo Fisher Scientific Inc. (United States), Sartorius AG (Germany), Danaher Corporation (United States), Merck KGaA (Germany), Mettler-Toledo International Inc. (United States), Hamilton Company (United States), Parker Hannifin Corporation (United States), PreSens Precision Sensing GmbH (Germany), Saint-Gobain S.A. (France), Dover Corporation (United States).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
